Supplier Research

Researchers Treat MRSA with Vitamin B3

September 11, 2012

A new study from the Journal of Clinical Investigation points to vitamin B3 as a potential way to treat serious staph infections, or MRSA. Physicians at Cedars-Sinai Medical Center, Los Angeles and the Linus Pauling Institute at Oregon State University collaborated to conduct a study in mice and human blood cells and found that high doses of B3, or niacin, was able to kill off Staphylococcus aureus(S. aureus) by 1,000 fold, particularly those resistant to antibiotics.
"This could give us a new way to treat staph infections that can be deadly, and might be used in combination with current antibiotics," said study author Adrian Gombart, an associate professor of microbiology at Oregon State University. "It's a way to tap into the power of the innate immune system and stimulate it to provide a more powerful and natural immune response."
For further information: http://www.jci.org/articles/view/62070?key=a39ce7efc2f764ede04

Related Health Conditions:

Related Market Segments:

  • Brain Saver Solutions

    Brain Saver Solutions

    Alan Richman, Contributing Writer||December 5, 2016
    Lifestyle habits and nutraceuticals may help keep minds alert and memories alive.

  • Active Nutrition for All Walks of Life

    Active Nutrition for All Walks of Life

    Sean Moloughney, Editor||November 1, 2016
    Companies develop products to meet the athletic needs of everyday consumers.

  • Delivery Trends for Ingredient Platforms on the Rise

    Delivery Trends for Ingredient Platforms on the Rise

    Stan Glab & Missy Lowery, Senior Formulator & Senior Manager, Marketing, Capsugel||October 3, 2016
    Creative hard capsule technologies demonstrate how dosage delivery forms matter.